rs5728

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001039.4(SCNN1G):​c.*572A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.409 in 174,056 control chromosomes in the GnomAD database, including 14,991 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 13204 hom., cov: 33)
Exomes 𝑓: 0.39 ( 1787 hom. )

Consequence

SCNN1G
NM_001039.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0450

Publications

13 publications found
Variant links:
Genes affected
SCNN1G (HGNC:10602): (sodium channel epithelial 1 subunit gamma) Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the gamma subunit, and mutations in this gene have been associated with Liddle syndrome. [provided by RefSeq, Apr 2009]
SCNN1G Gene-Disease associations (from GenCC):
  • Liddle syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • bronchiectasis with or without elevated sweat chloride 3
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • Liddle syndrome 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • pseudohypoaldosteronism, type IB1, autosomal recessive
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 16-23216041-A-G is Benign according to our data. Variant chr16-23216041-A-G is described in ClinVar as Benign. ClinVar VariationId is 318367.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.442 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCNN1GNM_001039.4 linkc.*572A>G 3_prime_UTR_variant Exon 13 of 13 ENST00000300061.3 NP_001030.2 P51170A5X2V1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCNN1GENST00000300061.3 linkc.*572A>G 3_prime_UTR_variant Exon 13 of 13 1 NM_001039.4 ENSP00000300061.2 P51170

Frequencies

GnomAD3 genomes
AF:
0.412
AC:
62613
AN:
152030
Hom.:
13174
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.381
Gnomad AMI
AF:
0.515
Gnomad AMR
AF:
0.419
Gnomad ASJ
AF:
0.426
Gnomad EAS
AF:
0.184
Gnomad SAS
AF:
0.329
Gnomad FIN
AF:
0.432
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.447
Gnomad OTH
AF:
0.418
GnomAD4 exome
AF:
0.390
AC:
8535
AN:
21908
Hom.:
1787
Cov.:
0
AF XY:
0.382
AC XY:
4263
AN XY:
11156
show subpopulations
African (AFR)
AF:
0.328
AC:
88
AN:
268
American (AMR)
AF:
0.416
AC:
1245
AN:
2990
Ashkenazi Jewish (ASJ)
AF:
0.422
AC:
109
AN:
258
East Asian (EAS)
AF:
0.143
AC:
181
AN:
1262
South Asian (SAS)
AF:
0.325
AC:
709
AN:
2184
European-Finnish (FIN)
AF:
0.371
AC:
231
AN:
622
Middle Eastern (MID)
AF:
0.313
AC:
20
AN:
64
European-Non Finnish (NFE)
AF:
0.417
AC:
5488
AN:
13150
Other (OTH)
AF:
0.418
AC:
464
AN:
1110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
238
476
714
952
1190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.412
AC:
62700
AN:
152148
Hom.:
13204
Cov.:
33
AF XY:
0.406
AC XY:
30210
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.382
AC:
15840
AN:
41506
American (AMR)
AF:
0.419
AC:
6409
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.426
AC:
1479
AN:
3472
East Asian (EAS)
AF:
0.184
AC:
951
AN:
5176
South Asian (SAS)
AF:
0.332
AC:
1602
AN:
4826
European-Finnish (FIN)
AF:
0.432
AC:
4563
AN:
10560
Middle Eastern (MID)
AF:
0.446
AC:
131
AN:
294
European-Non Finnish (NFE)
AF:
0.447
AC:
30364
AN:
67988
Other (OTH)
AF:
0.422
AC:
893
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1945
3890
5834
7779
9724
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
596
1192
1788
2384
2980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.434
Hom.:
39808
Bravo
AF:
0.411
Asia WGS
AF:
0.296
AC:
1028
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 14, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pseudohypoaldosteronism, type IB1, autosomal recessive Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Liddle syndrome 2 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
4.8
DANN
Benign
0.76
PhyloP100
-0.045
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5728; hg19: chr16-23227362; API